Pentagon issues new guidance for testosterone testing after rescinding previous one

The Pentagon issued new guidance late Thursday mandating testosterone deficiency screening for male active-duty and reserve service members over age 30, after rescinding previous guidance earlier this month. The updated policy aims to establish uniform screening and treatment pathways across the Defense Health Agency, addressing male testosterone deficiency in a standardized manner.